Aubrey Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,847
| Closed | -$227K | – | 69 |
|
|
2023
Q4 | $227K | Hold |
1,847
| – | – | 0.1% | 60 |
|
|
2023
Q3 | $226K | Hold |
1,847
| – | – | 0.13% | 53 |
|
|
2023
Q2 | $229K | Hold |
1,847
| – | – | 0.15% | 48 |
|
|
2023
Q1 | $270K | Hold |
1,847
| – | – | 0.16% | 43 |
|
|
2022
Q4 | $294K | Hold |
1,847
| – | – | 0.24% | 39 |
|
|
2022
Q3 | $246K | Hold |
1,847
| – | – | 0.21% | 39 |
|
|
2022
Q2 | $288K | Hold |
1,847
| – | – | 0.23% | 43 |
|
|
2022
Q1 | $288K | Sell |
1,847
-700
| -27% | -$109K | 0.16% | 56 |
|
|
2021
Q4 | $324K | Buy |
2,547
+250
| +11% | +$31.9K | 0.13% | 35 |
|
|
2021
Q3 | $299K | Sell |
2,297
-508
| -18% | -$66.1K | 0.09% | 36 |
|
|
2021
Q2 | $498K | Hold |
2,805
| – | – | 0.15% | 31 |
|
|
2021
Q1 | $461K | Buy |
+2,805
| New | +$461K | 0.13% | 35 |
|